The evolving role of sentinel lymph node biopsy for breast cancer

European Journal of Surgical Oncology

Volumn 29, Issue 5, 2003, Pages 423-425

  Singh Ranger, G ^a   Mokbel, Kefah ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Adjuvant therapy; Axillary nodes; Breast cancer; Sentinel lymph node biopsy

Indexed keywords

ANTINEOPLASTIC AGENT; TAMOXIFEN;

AXILLARY LYMPH NODE; BREAST CANCER; CANCER SCINTISCANNING; CANCER SURVIVAL; CARCINOMA IN SITU; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; HIGH RISK PATIENT; HUMAN; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MEDICAL RESEARCH; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RELIABILITY; REVIEW; SENTINEL LYMPH NODE BIOPSY;

EID: 0037662790     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0748-7983(03)00038-6     Document Type: Review

References (24)

1. Fisher B, Bauer M, Wickerham DL, Redmond CK, Fisher ER, Cruz AB et al. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. Cancer 1983; 52(9): 1551-7.
2. Keleman PR, Lowe V, Phillips N. Positron emission tomography and sentinel lymph node dissection in breast cancer. Clin Breast Cancer 2002; 3(1): 73-7.
3. Yang JH, Nam SJ, Lee TS, Lee HK, Jung SH, Kim BT. Comparison of intraoperative frozen section analysis of sentinel node with preoperative positron emission tomography in the diagnosis of axillary lymph node status in breast cancer patients. Jpn J Clin Oncol 2001; 31(1): 1-6.
4. Motomura K, Inaji H, Komoike Y, Kasugai T, Nagumo S, Hasegawa Y et al. Gamma probe and ultrasonographically-guided fine-needle aspiration biopsy of sentinel lymph nodes in breast cancer patients. Eur J Surg Oncol 2001; 27(2): 141-5.
5. de Kanter AY, van Eijck CH, van Geel AN, Kruijt RH, Henzen SC, Paul MA et al. Multicentre study of ultrasonographically guided axillary node biopsy in patients with breast cancer. Br J Surg 1999; 86(11): 1459-62.
6. Cserni G. The reliability of sampling three to six nodes for staging breast cancer. J Clin Pathol 1999; 52(9): 681-3.
7. Chetty U, Jack W, Prescott RJ, Tyler C, Rodger A. Management of the axilla in operable breast cancer treated by breast conservation: a randomised clinical trial. Edinburgh breast unit. Br J Surg 2000; 87(2): 163-9.
8. Sinha PS, Thrush S, Bendall S, Bates T. Does radical surgery to the axilla give a survival advantage in more severe breast cancer? Eur J Cancer 2002; 38(11): 1474-7.
9. Weir L, Speers C, D'yachkova Y, Olivotto IA. Prognostic significance of the number of axillary lymph nodes removed in patients with node-negative breast cancer. J Clin Oncol 2002; 20(7): 1793-9.
10. Giuliano AE, Haigh PI, Brennan MB, Hansen NM, Kelley MC, Ye W et al. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol 2000; 18(13): 2553-9.
11. Veronesi U, Galimberti V, Zurrida S, Pigatto F, Veronesi P, Robertson C et al. Sentinel lymph node biopsy as an indicator for axillary dissection in early breast cancer. Eur J Cancer 2001; 37(4): 454-8.
12. Shimazu K, Tamaki Y, Taguchi T, Takamura Y, Noguchi S. Comparison between periareolar and peritumoral injection of radiotracer for sentinel lymph node biopsy in patients with breast cancer. Surgery 2002; 131(3): 277-86.
13. Kim T, Agboola O, Lyman GH. Lymphatic mapping and sentinel lymph node sampling in breast cancer: a metanalysis. ASCO 2002; 139. abstract.
14. Wong SL, Edwards MJ, Chao C, Tuttle TM, Noyes RD, Carlson DJ et al. The effect of prior breast biopsy and concurrent definitive breast procedure on success and accuracy of sentinel lymph node biopsy. Ann Surg Oncol 2002; 9(3): 272-7.
15. Chung MH, Ye W, Giuliano AE. Role for sentinel lymph node dissection in the management of large (> or = 5c) invasive breast cancer. Ann Surg Oncol 200 1; 8(9): 688-92.
16. Mertz L, Masthelin C, Marin C, Gairard B, Chenard MP, Brettes JP et al. Subareolar injection of 99m-Tc sulphur colloid for sentinel node identification in multifocal invasive breast cancer. Bull Cancer 1999; 86(11): 939-45.
17. Stearns VCA, Slack R, Penannen MF, Hayes DF, Tsangaris TN. Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer. Ann Surg Oncol 2002; 9(3): 235-42.
18. Brady EW. Sentinel lymph node mapping following neoadjuvant chemotherapy for breast cancer. Breast J 2002; 8(2): 97-100.
19. Haigh PI, Hansen NM, Qi K, Giuliano AE. Biopsy method and excision volume do not affect success rate of subsequent sentinel lymph node dissection in breast cancer. Ann Surg Oncol 2000; 7(1): 21-7.
20. Port ER, Fey J, Gemignani ML, Heerdt AS, Montgomery LL, Petrek JA et al. Reoperative sentinel lymph node biopsy: a new option for patients with primary or locally recurrent breast carcinoma. J Am Coll Surg 2002; 195(2): 167-72.
21. Henry-Tillman RS, Korourian S, Rubio IT, Johnson AT, Mancino A, Massol N et at. Intraoperative touch preparation for sentinel lymph node biopsy: a four year experience. Ann Surg Oncol 2002; 9(4): 333-9.
22. Braun S, Cevatli BS, Assemi C, Janni W, Kentenich CR, Schindlbech C et al. Comparative analysis of micrometastasis to the bone marrow and lymph nodes of node-negative breast cancer patients receiving no adjuvant therapy. J Clin Oncol 200 1; 19(5): 1468-75.
23. Haid A, Koberle-Wuhrer R, Knauer M, Burtscher J, Fritzsche H, Peschina W et al. Morbidity of breast cancer patients following complete axillary dissection or sentinel node biopsy only: a comparative evaluation. Breast Cancer Res Treat 2002; 73(l): 31-6.
24. Cserni G. Sentinel lymph node biopsy as a tool for the staging of ductal carcinoma in situ in patients with breast carcinoma. Surg Today 2002; 32(2): 99-103.